BioLife Solutions Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.1% | 39.3% | 39.2% | 37.4% | 37.0% | 41.3% | 35.8% | 29.7% | 30.3% | 31.3% | 28.5% | 29.2% | 31.6% | 37.0% | 37.6% | 45.4% | 42.8% | 45.9% | 44.8% | 59.5% | 73.6% | 83.5% | 67.5% | 64.6% | 66.3% | 68.4% | 62.8% | 62.3% | 49.1% | 71.7% | 33.6% | 33.0% | 28.7% | – | 34.1% | 35.4% | 36.1% | 32.5% | 36.7% | 35.8% | 35.5% | |
| 56.9% | 60.7% | 60.8% | 62.6% | 63.0% | 58.7% | 64.2% | 70.3% | 69.7% | 68.7% | 71.5% | 70.8% | 68.4% | 63.0% | 62.4% | 54.6% | 57.2% | 54.1% | 55.2% | 40.5% | 26.4% | 16.5% | 32.5% | 35.4% | 33.7% | 31.6% | 37.2% | 37.7% | 50.9% | 28.3% | 66.4% | 67.0% | 71.3% | – | 65.9% | 64.6% | 63.9% | 67.5% | 63.3% | 64.2% | 64.5% | |
| 23.3% | 19.0% | 12.1% | 12.5% | 9.9% | 9.4% | 9.1% | 6.3% | 5.9% | 5.8% | 6.4% | 11.0% | 19.8% | 9.0% | 13.7% | 14.9% | 15.3% | 12.6% | 11.8% | 9.8% | 9.5% | 9.6% | 10.4% | 8.5% | 8.4% | 9.4% | 11.0% | 13.0% | 15.9% | 13.4% | 19.2% | 10.3% | 6.7% | – | 9.2% | 10.7% | 9.7% | 0.4% | 9.6% | 10.4% | 8.2% | |
| 48.7% | 42.4% | 46.6% | 42.1% | 37.7% | 39.1% | 35.5% | 26.9% | 27.5% | 32.1% | 38.2% | 32.9% | 34.2% | 27.9% | 25.8% | 33.0% | 31.1% | 31.9% | 28.7% | 22.9% | 29.8% | 27.9% | 31.8% | 28.7% | 29.2% | 30.6% | 39.4% | 46.3% | 45.9% | 39.6% | 56.4% | 47.3% | 37.1% | – | 48.0% | 44.8% | 43.0% | 56.2% | 44.4% | 37.6% | 44.3% | |
| 110.2% | 88.6% | 80.4% | 75.9% | 64.1% | 65.7% | 60.6% | 45.5% | 47.1% | 49.5% | 61.6% | 59.5% | 80.0% | 70.0% | 59.4% | 54.2% | 68.3% | 86.4% | 61.0% | 55.1% | 59.5% | 62.8% | 54.5% | 224.3% | 62.5% | 145.1% | 73.3% | 74.1% | 116.5% | 68.4% | 84.3% | 73.6% | 76.4% | – | 71.0% | 130.1% | 64.2% | 36.5% | 63.2% | 58.3% | 57.2% | |
| -53.3% | -27.9% | -19.6% | -13.3% | -1.1% | -7.0% | 3.7% | 24.8% | 22.6% | 19.1% | 9.8% | 11.1% | -11.7% | -7.0% | 3.0% | 0.4% | -11.0% | -32.2% | -5.8% | -14.6% | -33.0% | -46.2% | -22.0% | -188.9% | -28.8% | -113.5% | -36.1% | -36.4% | -65.6% | -40.2% | -17.9% | -6.6% | -5.1% | – | -5.1% | -65.5% | -0.3% | 31.0% | 0.1% | 6.0% | 7.2% | |
| 5.9% | 6.8% | 7.5% | 6.5% | 0.0% | 1.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | 0.1% | 0.4% | 0.6% | 0.3% | 0.5% | 0.1% | 0.0% | 1.1% | 1.1% | 1.3% | 1.9% | 1.5% | 1.1% | 1.8% | 0.9% | – | – | 2.7% | 1.8% | 0.8% | – | – | – | |
| -59.3% | -158.4% | -36.8% | -30.0% | -10.8% | -17.8% | 0.1% | 22.0% | 23.3% | 16.4% | -332.1% | 63.5% | 155.5% | -166.1% | 183.4% | -165.1% | -10.0% | -36.6% | -6.6% | -15.0% | -14.5% | -45.7% | -22.1% | -189.0% | -26.8% | -113.7% | -36.1% | -18.9% | -66.6% | -41.0% | -17.3% | -28.2% | -5.7% | – | -1.8% | -61.8% | 2.5% | 17.9% | 4.5% | 9.7% | 7.8% | |
| -13.9% | 41.2% | 17.2% | 16.7% | 9.7% | 10.8% | 0.0% | 2.8% | 23.3% | 4.2% | 3.6% | 0.6% | -148.5% | -18.6% | -12.7% | 150.9% | 0.6% | -22.2% | 7.6% | -40.2% | -14.8% | -6.9% | -1.7% | -9.2% | -1.5% | -0.2% | 0.2% | 0.0% | 0.5% | -0.1% | 0.1% | 0.0% | -0.1% | – | 0.1% | 0.5% | 0.3% | -0.9% | 0.2% | -148.8% | -41.2% | |
| -45.4% | -147.7% | -36.8% | -30.0% | -10.8% | -17.8% | 0.1% | 22.0% | 23.3% | 16.4% | -332.1% | 63.5% | 155.5% | -147.5% | 183.4% | -165.1% | -10.0% | -14.5% | -6.6% | 25.2% | 0.2% | -38.8% | -20.5% | -179.8% | -25.3% | -113.5% | -36.4% | -34.9% | -123.6% | -40.9% | -55.4% | -105.1% | -5.6% | – | -1.9% | -62.3% | 2.2% | 18.8% | 4.3% | 158.4% | 49.1% | |
| -53.3% | -147.6% | -25.5% | -20.1% | -7.9% | -15.3% | 5.7% | 23.6% | 24.9% | 18.1% | 9.2% | 66.7% | 163.5% | 4.6% | 10.0% | -7.1% | -3.2% | -44.9% | 7.3% | 1.4% | -21.6% | -29.3% | -9.2% | -177.9% | -16.2% | -18.1% | -26.6% | -5.7% | -50.7% | -11.1% | -4.1% | 5.4% | 2.8% | – | 0.7% | -56.4% | 4.4% | 26.1% | 2.6% | 10.2% | 9.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.